Incannex Healthcare
IXHL
1 hedge funds and large institutions have $21.5K invested in Incannex Healthcare in 2023 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
50% less funds holding
Funds holding: 2 → 1 (-1)
51% less capital invested
Capital invested by funds: $44.2K → $21.5K (-$22.7K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$11.4K |
| 2 |
Morgan Stanley
New York
|
-$6.04K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $21.4K | -$11.4K | -47 | -33% |
|
2
RhumbLine Advisers
Boston,
Massachusetts
| $100 | – | – | – |
|
|
3
Morgan Stanley
New York
| – | -$6.04K | -23 | Closed |
|
IXHL Hedge Fund Activity: Q2 2023 in Review
1 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Incannex Healthcare (IXHL) for Q2 2023, worth a combined $21.5K — down 51% from $44.2K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of IXHL and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was Jane Street, cutting an estimated $11.4K.
- 1 institutional investor held Incannex Healthcare (IXHL) as of Q2 2023, down from 2 in Q1 2023.
- Funds reported $21.5K of Incannex Healthcare stock for Q2 2023, down 51% quarter-over-quarter.
- 0 funds opened new Incannex Healthcare positions in Q2 2023 and 1 closed out, a net change of -1 holder.
- The largest Incannex Healthcare seller in Q2 2023 was Jane Street, an estimated $11.4K sold.
Based on aggregated 13F filings for Q2 2023.